IDBI Bank announced that its standalone net profit jumped 44% to Rs 1,628 crore in Q4 FY24 as compared with 1,133 crore in Q4 FY23.
Posts in category Business Standard
Aurobindo Pharma’s Rajasthan-based facility concludes US FDA audit with 9 observations (04-05-2024)
Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected the Unit-II, a formulation manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialities that is situated at Bhiwadi, Rajasthan.
Aurobindo Pharma’s Rajasthan-based facility concludes US FDA audit with 9 observations (04-05-2024)
Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected the Unit-II, a formulation manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialities that is situated at Bhiwadi, Rajasthan.
IDBI Bank consolidated net profit rises 36.83% in the March 2024 quarter (04-05-2024)
Total Operating Income rise 22.08% to Rs 6994.70 crore
IDBI Bank consolidated net profit rises 36.83% in the March 2024 quarter (04-05-2024)
Total Operating Income rise 22.08% to Rs 6994.70 crore
Central Depository Services (India) consolidated net profit rises 104.85% in the March 2024 quarter (04-05-2024)
Sales rise 92.98% to Rs 240.78 crore
Central Depository Services (India) consolidated net profit rises 104.85% in the March 2024 quarter (04-05-2024)
Sales rise 92.98% to Rs 240.78 crore
Vardhman Acrylics standalone net profit rises 34.95% in the March 2024 quarter (04-05-2024)
Sales decline 15.16% to Rs 68.38 crore
Vardhman Acrylics standalone net profit rises 34.95% in the March 2024 quarter (04-05-2024)
Sales decline 15.16% to Rs 68.38 crore
Nila Infrastructures consolidated net profit rises 26550.00% in the March 2024 quarter (04-05-2024)
Sales rise 101.04% to Rs 86.75 crore